296 related articles for article (PubMed ID: 28511006)
21. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.
Bilang-Bleuel A; Revah F; Colin P; Locquet I; Robert JJ; Mallet J; Horellou P
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8818-23. PubMed ID: 9238061
[TBL] [Abstract][Full Text] [Related]
22. Compacted DNA nanoparticle gene transfer of GDNF to the rat striatum enhances the survival of grafted fetal dopamine neurons.
Yurek DM; Flectcher AM; Kowalczyk TH; Padegimas L; Cooper MJ
Cell Transplant; 2009; 18(10):1183-96. PubMed ID: 19650971
[TBL] [Abstract][Full Text] [Related]
23. Polylysine-modified polyethylenimine (PEI-PLL) mediated VEGF gene delivery protects dopaminergic neurons in cell culture and in rat models of Parkinson's Disease (PD).
Sheikh MA; Malik YS; Xing Z; Guo Z; Tian H; Zhu X; Chen X
Acta Biomater; 2017 May; 54():58-68. PubMed ID: 28025049
[TBL] [Abstract][Full Text] [Related]
24. Electroacupuncture Therapy Ameliorates Motor Dysfunction via Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor in a Mouse Model of Parkinson's Disease.
Pak ME; Ahn SM; Jung DH; Lee HJ; Ha KT; Shin HK; Choi BT
J Gerontol A Biol Sci Med Sci; 2020 Mar; 75(4):712-721. PubMed ID: 31644786
[TBL] [Abstract][Full Text] [Related]
25. Increased brain bio-distribution and chemical stability and decreased immunogenicity of an engineered variant of GDNF.
Smith RC; O'Bryan LM; Mitchell PJ; Leung D; Ghanem M; Wilson JM; Hanson JC; Sossick S; Cooper J; Huang L; Merchant KM; Lu J; O'Neill MJ
Exp Neurol; 2015 May; 267():165-76. PubMed ID: 25771799
[TBL] [Abstract][Full Text] [Related]
26. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
27. Delivery of sonic hedgehog or glial derived neurotrophic factor to dopamine-rich grafts in a rat model of Parkinson's disease using adenoviral vectors Increased yield of dopamine cells is dependent on embryonic donor age.
Torres EM; Monville C; Lowenstein PR; Castro MG; Dunnett SB
Brain Res Bull; 2005 Dec; 68(1-2):31-41. PubMed ID: 16325002
[TBL] [Abstract][Full Text] [Related]
28. Comparison of fetal mesencephalic grafts, AAV-delivered GDNF, and both combined in an MPTP-induced nonhuman primate Parkinson's model.
Redmond DE; McEntire CR; Kingsbery JP; Leranth C; Elsworth JD; Bjugstad KB; Roth RH; Samulski RJ; Sladek JR
Mol Ther; 2013 Dec; 21(12):2160-8. PubMed ID: 23913185
[TBL] [Abstract][Full Text] [Related]
29. Focused ultrasound enhanced intranasal delivery of brain derived neurotrophic factor produces neurorestorative effects in a Parkinson's disease mouse model.
Ji R; Smith M; Niimi Y; Karakatsani ME; Murillo MF; Jackson-Lewis V; Przedborski S; Konofagou EE
Sci Rep; 2019 Dec; 9(1):19402. PubMed ID: 31852909
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat.
Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC
Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445
[TBL] [Abstract][Full Text] [Related]
31. Complementation of dopaminergic signaling by Pitx3-GDNF synergy induces dopamine secretion by multipotent Ntera2 cells.
Eskandarian Boroujeni M; Aliaghaei A; Maghsoudi N; Gardaneh M
J Cell Biochem; 2020 Jan; 121(1):200-212. PubMed ID: 31310388
[TBL] [Abstract][Full Text] [Related]
32. Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease.
Biju K; Zhou Q; Li G; Imam SZ; Roberts JL; Morgan WW; Clark RA; Li S
Mol Ther; 2010 Aug; 18(8):1536-44. PubMed ID: 20531393
[TBL] [Abstract][Full Text] [Related]
33. Intranasal Delivery of pGDNF DNA Nanoparticles Provides Neuroprotection in the Rat 6-Hydroxydopamine Model of Parkinson's Disease.
Aly AE; Harmon BT; Padegimas L; Sesenoglu-Laird O; Cooper MJ; Waszczak BL
Mol Neurobiol; 2019 Jan; 56(1):688-701. PubMed ID: 29779176
[TBL] [Abstract][Full Text] [Related]
34. Implantation of glial cell line-derived neurotrophic factor-expressing adipose tissue-derived stromal cells in a rat Parkinson's disease model.
Xu R; Wu J; Lang L; Hu J; Tang H; Xu J; Sun B
Neurol Res; 2020 Aug; 42(8):712-720. PubMed ID: 32567526
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound targeted CNS gene delivery for Parkinson's disease treatment.
Fan CH; Lin CY; Liu HL; Yeh CK
J Control Release; 2017 Sep; 261():246-262. PubMed ID: 28690161
[TBL] [Abstract][Full Text] [Related]
36. A preliminary study of Parkinson's gene therapy via sono-magnetic sensing gene vector for conquering extra/intracellular barriers in mice.
Wu CY; Huang RY; Liao EC; Lin YC; Ho YJ; Chang CW; Chan HL; Huang YZ; Hsieh TH; Fan CH; Yeh CK
Brain Stimul; 2020; 13(3):786-799. PubMed ID: 32289709
[TBL] [Abstract][Full Text] [Related]
37. GDNF revisited: A novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution.
Grondin R; Littrell OM; Zhang Z; Ai Y; Huettl P; Pomerleau F; Quintero JE; Andersen AH; Stenslik MJ; Bradley LH; Lemmon J; O'Neill MJ; Gash DM; Gerhardt GA
Neuropharmacology; 2019 Mar; 147():28-36. PubMed ID: 29857941
[TBL] [Abstract][Full Text] [Related]
38. Focused ultrasound-induced blood brain-barrier opening enhanced vascular permeability for GDNF delivery in Huntington's disease mouse model.
Lin CY; Tsai CH; Feng LY; Chai WY; Lin CJ; Huang CY; Wei KC; Yeh CK; Chen CM; Liu HL
Brain Stimul; 2019; 12(5):1143-1150. PubMed ID: 31079989
[TBL] [Abstract][Full Text] [Related]
39. Adeno-associated virus type 2 vector-mediated glial cell line-derived neurotrophic factor gene transfer induces neuroprotection and neuroregeneration in a ubiquitin-proteasome system impairment animal model of Parkinson's disease.
Du Y; Zhang X; Tao Q; Chen S; Le W
Neurodegener Dis; 2013; 11(3):113-28. PubMed ID: 22626907
[TBL] [Abstract][Full Text] [Related]
40. Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease.
Lapchak PA; Araujo DM; Hilt DC; Sheng J; Jiao S
Brain Res; 1997 Nov; 777(1-2):153-60. PubMed ID: 9449424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
